MILFORD, Pa., March 11, 2015 /PRNewswire/ -- Manzo
Post# of 96
Posted On: 03/11/2015 9:22:34 AM
MILFORD, Pa., March 11, 2015 /PRNewswire/ -- Manzo Pharmaceuticals, Inc. (MNZO), today announced Manzo Pharmaceuticals has identified Medicus Research to perform the human clinical study of Lacto-Freedom probiotic, a necessary step in order to take the ground breaking product to market.
The goal of this human study is to use science to substantiate that the Lacto-Freedom™ Probiotic demonstrates efficacy in decreasing symptoms of Lactose Intolerance when consuming a glass of milk. Dr. Jay Udani, CEO of Medicus Reseach, concurred that the FDA recognizes genetically modified probiotics, like Lacto-Freedom probiotic, as nutritional supplements and there are no additional regulations that pertain to genetically modified probiotics. Dr. Jay Udeni has expertise in FDA regulations, probiotics development and deployment, clinical studies, as well as Federal Trade Commission regulation compliance. Medicus Research designs its clinical trials to guarantee that its studies are structurally and functionally compliant, and follow the strict guidelines that are in place. Medicus has established Good Clinical Practice and FDA compliant procedures, internal quality assurance processes, and proprietary management technology systems, which ensure the highest quality for all aspects of the study. Consumers ca
The goal of this human study is to use science to substantiate that the Lacto-Freedom™ Probiotic demonstrates efficacy in decreasing symptoms of Lactose Intolerance when consuming a glass of milk. Dr. Jay Udani, CEO of Medicus Reseach, concurred that the FDA recognizes genetically modified probiotics, like Lacto-Freedom probiotic, as nutritional supplements and there are no additional regulations that pertain to genetically modified probiotics. Dr. Jay Udeni has expertise in FDA regulations, probiotics development and deployment, clinical studies, as well as Federal Trade Commission regulation compliance. Medicus Research designs its clinical trials to guarantee that its studies are structurally and functionally compliant, and follow the strict guidelines that are in place. Medicus has established Good Clinical Practice and FDA compliant procedures, internal quality assurance processes, and proprietary management technology systems, which ensure the highest quality for all aspects of the study. Consumers ca
(0)
(0)Manzo Pharmaceuticals Inc. (MNZO) Stock Research Links
Scroll down for more posts ▼